Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells

Journal of Cellular Biochemistry

Volumn 99, Issue 4, 2006, Pages 1010-1020

  Li, Jingxia ^a   Song, Lun ^a   Zhang, Dongyun ^a   Wei, Lixin ^b   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell transformation; COX 2; iNOS; NFAT3; TPA

Indexed keywords

AMINOGUANIDINE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL TRANSFORMATION; CELLS TRAIN CI41; CONTROLLED STUDY; ENZYME INHIBITION; EPIDERMIS CELL; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR PROMOTION; UPREGULATION;

ANIMALS; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; ENZYME INHIBITORS; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS);

EID: 33746848336     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20834     Document Type: Article

References (42)

1. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, DeCaprio JA, Modiano JF, Burakoff SJ. 2002. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10:1071-1081.
2. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA, Viola JP. 2002. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: Evidence of its involvement in the control of cyclin gene expression. FASEB J 16:1940-1942.
3. Chen T, Stoner GD. 2004. Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis. Mol Carcinog 40:232-240.
4. Chun KS, Cha HH, Shin JW, Na HK, Park KK, Chung WY, Surh YJ. 2004. Nitric oxide induces expression of cyclooxygenase-2 in mosue skin through activation of NF-κB. Carcinogenesis 25:445-454.
5. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK, Schulze-Luehrmann J, Santner-Nanan B, Feoktistova E, Konig T, Avosa A, Schmitt E, Berberich-Siebelt F, Schimpl A, Serfling E. 2002. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16:881-895.
6. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. 1995. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55:727-730.
7. Crowell JA, Steele VE, Sigman CC, Fay JR. 2003. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2:815-823.
8. De Gregorio R, Iniguez MA, Fresno M, Alemany S. 2001. Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem 276:27003-27009.
9. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Moris SM, Billiar TR, Geller DA. 1996. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93:1054-1059.
10. Dhar A, Brindley JM, Stark C, Citro ML, Keefer LM, Colbum NH. 2003. Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther 2:1285-1293.
11. Di Rosa M, Ialenti A, Ianaro A, Sautebin L. 1996. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids 54:4997-5001.
12. Duque J, Fresno M, Iniguez MA. 2005. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: Involvement in the regulation of cyclooxygenase-2. J Biol Chem 280:8686-8693.
13. Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M, Crabtree GR. 2003. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell 113:657-670.
14. Hinz B, Brune K. 2002. Cyclooxygenase-2-10 years later. J Pharmacol Exp Ther 300:367-375.
15. Hogan PG, Chen L, Nardone J, Rao A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205-2232.
16. Horsley V, Pavlath GK. 2002. NFAT: Ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156:771-774.
17. Huang C, Schmid PC, Ma WY, Schmid HH, Dong Z. 1997. Phosphatidylinositol- 3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J Biol Chem 272:4187-4194.
18. Huang C, Mattjus P, Ma W, Rincon M, Chen N, Brown RE, Dong Z. 2000. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice. J Biol Chem 275:9143-9149.
19. Huang C, Li J, Costa M, Zhang Z, Leonard SS, Castranova V, Vallyathan V, Ju G, Shi X. 2001. Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res 61:8051-8057.
20. Iniguez MA, Martinez-Martinez S, Punzon C, Redondo JM, Fresno M. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Bio Chem 275:23627-23635.
21. Islas-Carbajal MC, Covarrubias A, Grijalva G, Alvarez-Rodriguez A, Armendariz-Borunda J, Rincon-Sanchez AR. 2005. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int 25:131-140.
22. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A. 2002. The role of NFAT transcription factors in intergrin-mediated carcinoma invasion. Nat Cell Biol 4:540-544.
23. Jayanthi S, Deng X, Ladenheim B, McCoy MT, Cluster A, Cai NS, Cadet JL. 2005. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci USA 102:868-873.
24. Kleinert H, Pautz A, Linker K, Schwarz PM. 2004. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500:255-266.
25. Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, Ono M. 2004. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 18:300-310.
26. Liu Q, Chan STF, Mahendran R. 2003. Nitric oxide induces Cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. Carcinogenesis 24:637-642.
27. Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski MX, Dubois RN. 2001. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 120:1713-1719.
28. Neal JW, Clipstone NA. 2003. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J Biol Chem 278:17246-17254.
29. Ohshima H, Bartsch H. 1994. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutant Res 305:253-264.
30. Prescott SM, Fitzpatrick FA. 2000. Cyclooxygenase-2 and Carcinogenesis. Biochim Biophys Acta 1470:M69-M78.
31. Pu WT, Ma Q, Izumo S. 2003. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ Res 92:725-731.
32. Ranger AM, Gerstenfeld LC, Wang J, Kon T, Bae H, Gravallese EM, Glimcher MJ, Glimcher LH. 2000. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med 191:9-22.
33. Santini MP, Talora C, Seki T, Bolgan L, Dotto GP. 2001. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA 98:9575-9580.
34. Sheng H, Shao J, Morrow JD, Deauchamp RD, Dubios RN. 1998. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362-366.
35. Sheng H, Shao J, Washington MK, DuBois RN. 2001. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081.
36. Subbaramaiah K, Cole PA, Dannenberg AJ. 2002. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res 62:2522-2530.
37. Viola JP, Carvalho LD, Fonseca BP, Teixeira LK. 2005. NFAT transcription factors: From cell cycle to tumor development. Braz J Med Biol Res 38:335-344.
38. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. 2002. The role of nitric oxide in cancer. Cell Res 12:311-320.
39. Yamamoto S, Yamamoto K, Kurobe H, Yamashita R, Yamaguchi H, Ueda N. 1998. Transcriptional regulation of fatty acid cyclooxygenases-1 and -2. Int J Tissue React 20:17-22.
40. Yan Y, Li J, Ouyang W, Ma Q, Hu Y, Zhang D, Ding J, Qu Q, Subbaramaiah K, Huang C. 2006. Nuclear factor of activated T cells 3 (NFAT3) is specifically required for tumor necrosis factor-α (TNF-α)-induced Cyclooxygenase-2 (COX-2) expression and anchorage-independent growth of C141 Cells. Cell Sci (in press).
41. Zaichuk TA, Shroff EH, Emmanuel R, Filleur S, Nelius T, Volpert O. 2004. Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J Exp Med 199:1513-1522.
42. Zhang X, Ye J, Wang L, Manosroi J, Shi X, Rojanasakul Y. 2001. Rapid and sensitive assay of tumor necrosis factor-alpha gene transcription. Pharm Res 18:408-411.